Connection

Reeder Robinson to Histone Deacetylase Inhibitors

This is a "connection" page, showing publications Reeder Robinson has written about Histone Deacetylase Inhibitors.
  1. PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma. Cancer Chemother Pharmacol. 2022 05; 89(5):643-653.
    View in: PubMed
    Score: 0.184
  2. ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase Inhibitors. Cancer Res. 2020 08 15; 80(16):3279-3291.
    View in: PubMed
    Score: 0.163
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.